Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESS-PAR
NCT07491601Recruiting
- Start
- Jan 2025
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in hypoparathyroidism (2 arms). Primary endpoint: Symptomatic hypoparathyroidism (symptom score) with hypocalcemia. Started Jan 2025; status: recruiting.
02
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT07491601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07491601.